Dawei Rong
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Circular RNAs in diseases 10
- Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Weiwei Tang (24 shared papers)Xuehao Wang (13 shared papers)Betty Zhang (3 shared papers)Hongyong Cao (11 shared papers)Fan Wu (5 shared papers)Kai Fu (6 shared papers)Wenling Zhang (2 shared papers)Ye Cheng (3 shared papers)
- Journals
- Cancer Biomarkers (2 papers)Frontiers in Cell and Developmental Biology (2 papers)International Journal of Biological Sciences (2 papers)OncoTargets and Therapy (2 papers)Annals of Translational Medicine (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Dawei Rong
35 papers receiving 2.8k citations
Dawei Rong's Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 1.4k
- Hepatology 266
- Molecular Biology 1.8k
- Immunology 509
- Oncology 598
Countries citing papers authored by Dawei Rong
This map shows the geographic impact of Dawei Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Rong more than expected).
Fields of papers citing papers by Dawei Rong
This network shows the impact of papers produced by Dawei Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Rong. The network helps show where Dawei Rong may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects Hit paper breakdown → | 2020 | 752 |
| 2 | An emerging function of circRNA-miRNAs-mRNA axis in human diseases Hit paper breakdown → | 2017 | 399 |
| 3 | Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities Hit paper breakdown → | 2019 | 319 |
| 4 | Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing Hit paper breakdown → | 2022 | 194 |
| 5 | 2017 | 132 | |
| 6 | 2021 | 110 | |
| 7 | 2021 | 77 | |
| 8 | 2022 | 70 | |
| 9 | 2022 | 66 | |
| 10 | 2021 | 65 | |
| 11 | 2021 | 62 | |
| 12 | 2022 | 57 | |
| 13 | 2021 | 53 | |
| 14 | 2017 | 52 | |
| 15 | 2019 | 42 | |
| 16 | 2020 | 39 | |
| 17 | 2023 | 35 | |
| 18 | 2019 | 33 | |
| 19 | 2022 | 29 | |
| 20 | 2022 | 29 |
About Dawei Rong
Dawei Rong is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 35 papers that have together received 2.8k indexed citations. Recurring topics across this work include Circular RNAs in diseases (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Immune cells in cancer (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Hepatology (266 citations), Molecular Biology (1.8k citations), Immunology (509 citations) and Oncology (598 citations). Dawei Rong has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Weiwei Tang, Xuehao Wang, Betty Zhang, Hongyong Cao, Fan Wu, Kai Fu, Wenling Zhang, Ye Cheng, Zhouxiao Li and Handong Sun. Their work appears in journals such as Cancer Biomarkers, Frontiers in Cell and Developmental Biology, International Journal of Biological Sciences, OncoTargets and Therapy and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.